摘要
目的评价急性胰腺炎患者开展C反应蛋白(CRP)、淀粉酶(AMY)与脂肪酶(LPS)联合检测的早期诊断价值。方法随机抽取我院2015年7月-2017年7月收治的60例急性胰腺炎患者(轻型50例、重型10例)作为甲组,另选同期接收的60例非急性胰腺炎的急腹症患者作为乙组,60例健康体检者为丙组,所有患者均接受CRP、AMY、LPS联合检测,对比三组的检测结果。结果(1)丙组CRP、AMY、LPS均低于甲组(P<0.05);(2)甲组与乙组的CRP水平对比无差异(P>0.05),但乙组AMY、LPS均低于甲组(P<0.05);(3)轻型患者的CPR低于重型患者(P<0.05),两者的AMY、LPS对比无统计学差异(P>0.05)。结论联合检测展开C反应蛋白、淀粉酶以及脂肪酶有利于提升急性胰腺炎早期诊断结果的准确性,同时又能明确判断患者的病情程度,该诊断方式值得推广与使用。
Objective To evaluate the diagnostic value of C-reactive protein（CRP）,amylase（AMY）and lipase（LPS） in patients with acute pancreatitis. Methods 60 patients with acute pancreatitis（50 cases of mild type and 10 cases of severe type） were taken as group A, 60 cases of nonacute pancreatitis in the same period were taken as group B,60 healthy subjects were group C, all patients received CRP,AMY,LPS combined test, compared with the three groups of test results. Results CRP, AMY and LPS in the group C were lower than those in the group A（P〈0.05）. There was no significant difference in CRP level between group A and group B（P〈0.05）,but the levels of AMY and LPS in group B were lower than those in group A（P〈0.05）.There was no significant difference in AMY and LPS between the two groups（P〈0.05）.The CPR of the mild patients was lower than that of the severe patients（P〈0.05）. Conclusion Combined detection of C-reactive protein, amylase and lipase can improve the accuracy of early diagnosis of acute pancreatitis, and can clearly determine the patient＇s condition, the diagnosis is worthy of promotion and use.
出处
《中国继续医学教育》
2017年第31期41-43,共3页
China Continuing Medical Education
